Improving toxicology testing protocols using computer simulations.

Computer simulation can be used to integrate existing toxicity information within a biologically realistic framework. Simulation models calculate relevant measures of target tissue dose based on physiological, biochemical and physicochemical properties and readily support the dose, route, species and interchemical extrapolations necessary for human risk assessment. Because these models require very specific information, much of which can be obtained in vitro, they are much less dependent on extensive animal experiments than conventional risk assessment methods. With continuing development, simulation modeling will become an invaluable tool for improving experimental designs, for interpreting animal toxicity tests, and for estimating the importance of the animal toxicity observations for people.

[1]  J. Young,et al.  PHARMACOKINETICS OF INHALED OR INTRAPERITONEALLY ADMINISTERED STYRENE IN RATS , 1979 .

[2]  S. Safe,et al.  Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. , 1986, Annual review of pharmacology and toxicology.

[3]  H J Clewell,et al.  Biologically motivated models for chemical risk assessment. , 1989, Health physics.

[4]  M E Andersen,et al.  The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. , 1983, Toxicology and applied pharmacology.

[5]  M E Andersen,et al.  Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. , 1989, Toxicology and applied pharmacology.

[6]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[7]  E. Glover,et al.  [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification. , 1989, Molecular pharmacology.

[8]  M E Andersen,et al.  Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. , 1988, The Journal of pharmacology and experimental therapeutics.

[9]  M E Andersen,et al.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.

[10]  J. Young,et al.  Pharmacokinetics of inhaled styrene in human volunteers. , 1980, Toxicology and applied pharmacology.

[11]  M E Andersen,et al.  Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. , 1989, Toxicology and applied pharmacology.

[12]  H J Clewell,et al.  Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. , 1986, Toxicology and applied pharmacology.

[13]  J. Huff,et al.  Comparative toxicity and carcinogenicity of two chlorinated paraffins in F344/N rats and B6C3F1 mice. , 1987, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[14]  M. Andersen,et al.  Inhalation pharmacokinetics: evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios. , 1984, Toxicology and applied pharmacology.

[15]  F D Griffith,et al.  Animal toxicity studies with ammonium perfluorooctanoate. , 1980, American Industrial Hygiene Association journal.

[16]  R W D'Souza,et al.  Physiological Pharmacokinetic Models: Some Aspects of Theory, Practice and Potential , 1988, Toxicology and industrial health.

[17]  M E Andersen,et al.  Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. , 1988, Toxicology letters.

[18]  M E Andersen,et al.  Toxic effects of nonadecafluoro-n-decanoic acid in rats. , 1986, Toxicology and applied pharmacology.

[19]  H J Clewell,et al.  A physiologically based simulation approach for determining metabolic constants from gas uptake data. , 1986, Toxicology and applied pharmacology.

[20]  E. Glover,et al.  Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor. , 1989, Molecular pharmacology.

[21]  T. Gasiewicz,et al.  Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Evidence for a homologous nature among various mammalian species. , 1984, Molecular pharmacology.

[22]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[23]  Vera Fiserova-Bergerova,et al.  Determination and prediction of tissue-gas partition coefficients , 1986, International archives of occupational and environmental health.

[24]  D J Paustenbach,et al.  A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. , 1988, Toxicology letters.

[25]  D J Paustenbach,et al.  A physiologically based pharmacokinetic model for inhaled carbon tetrachloride. , 1988, Toxicology and applied pharmacology.

[26]  G. Lucier,et al.  Dioxin in soil: bioavailability after ingestion by rats and guinea pigs. , 1984, Science.

[27]  D J Paustenbach,et al.  A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. , 1990, Toxicology and applied pharmacology.

[28]  M. Andersen,et al.  Integration of Pharmacokinetics and Pathological Data in Dose Selection for Chronic Bioassays , 1988 .

[29]  H J Clewell,et al.  Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesis. , 1988, Toxicology letters.

[30]  M E Andersen,et al.  Modeling the tissue solubilities and metabolic rate constant (Vmax) of halogenated methanes, ethanes, and ethylenes. , 1988, Toxicology letters.

[31]  J. Q. Rose,et al.  The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat. , 1976, Toxicology and applied pharmacology.

[32]  D. M. Hetrick,et al.  Pharmacokinetics of tetrachloroethylene. , 1988, Toxicology and applied pharmacology.

[33]  M. Andersen,et al.  Risk Assessment Extrapolations and Physiological Modeling , 1985, Toxicology and industrial health.

[34]  H. Matthews,et al.  Pharmacokinetics of PCBs , 1984 .

[35]  M. Andersen,et al.  Physiologically based pharmacokinetic model for vinylidene chloride. , 1988, Toxicology and applied pharmacology.

[36]  R H Reitz,et al.  In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. , 1989, Toxicology and applied pharmacology.

[37]  S. Aust,et al.  Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. , 1987, Toxicology and applied pharmacology.